君圣泰医药-B
港股通 官网
( 02511.hk)
市盈率-5.55市净率4.43股息率0%上市时间2023-12-22股价2.65港币涨跌幅-1.12%成交金额17.94万港币换手率0.01%市值15.14亿港币H股市值15.14亿港币总股本5.71亿H股本5.71亿每手股数500上市至今年化投资收益率-44.94%港股通持仓占H股比例1.68% (2,527.30万港币2026-07-21)
所属三级行业药品 (恒生) 市盈率27.47市净率2.47股息率1.38%恒生:医疗保健业药品及生物科技药品
备注 (2): 双击编辑备注
发表讨论

君圣泰医药-B(02511) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1孔德偉Independent Non Executive Director2023-12-22--
2李靖Independent Non Executive Director2023-12-22--
3譚擘Independent Non Executive Director - A/F2023-12-22--
4于萌Executive Director2023-05-11--
5江峰Non Executive Director2022-11-16--
6馬立雄Non Executive Director2021-11-16--
7朱迅Non Executive DirectorChairman2020-11-30--
8李鋰Non Executive Director2018-10-16--
9劉利平Executive Director2018-02-28--